Second-generation anti-depressants and risk of new-onset seizures in the elderly

References

• WHO. Depression: a global public health concern; 2012 [cited 2015 Sept 18]. Available from: http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf
   Google Scholar
• Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13:153–160.
   PubMed Web of Science ®Google Scholar
• Correll CU, Detraux J, De Lepeleire J, et al. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14:119–136.
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA. 2002;287:2039.
   PubMed Web of Science ®Google Scholar
• Health at a glance: OECD indicators 2015. Chapter 10; 2015 [cited 2017 Oct 15]. Available from: http://www.oecd-ilibrary.org/sites/health_glance-2015-en/10/04/index.html?itemId=/content/chapter/health_glance-2015-68-en&mimeType=text/html
   Google Scholar
• Judge BS, Rentmeester LL. Antidepressant overdose-induced seizures [review]. Psychiatr Clin North Am. 2013;36:245–260.
   PubMed Web of Science ®Google Scholar
• CDC. Health, United States, 2013 with special feature on prescription drugs; 2013 [cited 2015 Sept 18]. Available from: http://www.cdc.gov/nchs/data/hus/hus13.pdf#listtables
   Google Scholar
• Wong J, Motulsky A, Eguale T, et al. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006–2015. JAMA. 2016;315:2230–2232.
   PubMed Web of Science ®Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47–53.
   PubMed Web of Science ®Google Scholar
• Arroll B, Elley CR, Fishman T, et al. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev. 2009;(3):CD007954.
   PubMed Web of Science ®Google Scholar
• Takayanagi Y, Spira AP, Bienvenu OJ, et al. Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study. J Clin Psychiatry. 2015;76:40–44.
   PubMed Web of Science ®Google Scholar
• Reichenpfader U, Gartlehner G, Morgan LC, et al. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf. 2014;37:19–31.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Mamdani MM, Wells PS, et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;323:655–658.
   PubMed Web of Science ®Google Scholar
• Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.
   PubMed Web of Science ®Google Scholar
• Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract. 1999;49:871–874.
   PubMed Web of Science ®Google Scholar
• McGirr A, Vohringer PA, Ghaemi SN, et al. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry. 2016;3:1138–1146.
   PubMed Web of Science ®Google Scholar
• Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ. 2005;330:396.
   PubMed Web of Science ®Google Scholar
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292:338–343.
   PubMed Web of Science ®Google Scholar
• Sharma T, Guski LS, Freund N, et al. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ. 2016;352:i65.
   PubMed Web of Science ®Google Scholar
• Judge BS, Rentmeester LL. Antidepressant overdose-induced seizures [review]. Neurologic Clin. 2011;29:565–580.
   PubMed Web of Science ®Google Scholar
• Iskandar JW, Schmidley JW, Sharma TR. Citalopram-induced seizures in a healthy adult taking an FDA-approved dosage: a case report. Prim Care Companion CNS Disord. 2011;13:pii: PCC.10l01113.
   Google Scholar
• Waring WS, Gray JA, Graham A. Predictive factors for generalized seizures after deliberate citalopram overdose. Br J Clin Pharmacol. 2008;66:861–865.
   PubMed Web of Science ®Google Scholar
• Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review [review]. J Clin Psychiatry. 1993;54:289–299.
   PubMed Web of Science ®Google Scholar
• Koster M, Grohmann R, Engel RR, et al. Seizures during antidepressant treatment in psychiatric inpatients–results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993-2008 [Multicenter Study Research Support, Non-U.S. Gov't]. Psychopharmacology. 2013;230:191–201.
   PubMed Web of Science ®Google Scholar
• Bloechliger M, Ceschi A, Ruegg S, et al. Risk of seizures associated with antidepressant use in patients with depressive disorder: follow-up study with a nested case-control analysis using the clinical practice research datalink. Drug Saf. 2016;39:307–321.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42:277–285.
   PubMed Web of Science ®Google Scholar
• Hill T, Coupland C, Morriss R, et al. Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database. BMC Psychiatry. 2015;15:315.
   PubMed Web of Science ®Google Scholar
• Finkelstein Y, Macdonald EM, Hollands S, et al. Long-term outcomes following self-poisoning in adolescents: a population-based cohort study. Lancet Psychiatry. 2015;2:532–539.
   PubMed Web of Science ®Google Scholar
• Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med. 2006;354:1352–1361.
   PubMed Web of Science ®Google Scholar
• Finkelstein Y, Macdonald EM, Li P, et al. Recurrence and mortality following severe cutaneous adverse reactions. JAMA. 2014;311:2231–2232.
   PubMed Web of Science ®Google Scholar
• Jettã N, Reid AY, Quan H, et al. How accurate is ICD coding for epilepsy? Epilepsia. 2010;51:62–69.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854–864.
   PubMed Web of Science ®Google Scholar
• Arbogast PG, Kaltenbach L, Ding H, et al. Adjustment for multiple cardiovascular risk factors using a summary risk score. Epidemiology. 2008;19:30–37.
   PubMed Web of Science ®Google Scholar
• Tadrous M, Gagne JJ, Sturmer T, et al. Disease risk score as a confounder summary method: systematic review and recommendations. Pharmacoepidemiol Drug Saf. 2013;22:122–129.
   PubMed Web of Science ®Google Scholar
• Pesola GR, Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department [case reports]. J Emerg Med. 2002;22:235–239.
   PubMed Web of Science ®Google Scholar
• Macaluso M, Zackula R, D'Empaire I, et al. Twenty percent of a representative sample of patients taking bupropion have abnormal, asymptomatic electroencephalographic findings. J Clin Psychopharmacol. 2010;30:312–317.
   PubMed Web of Science ®Google Scholar
• Peck AW, Stern WC, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion [comparative study review]. J Clin Psychiatry. 1983;44:(5 Pt 2):197–201.
   PubMed Web of Science ®Google Scholar
• Johnston JA, Lineberry CG, Ascher JA, et al. A 102-center prospective study of seizure in association with bupropion [clinical trial multicenter study]. J Clin Psychiatry. 1991;52:450–456.
   PubMed Web of Science ®Google Scholar
• Davidson J. Seizures and bupropion: a review. J Clin Psychiatry. 1989;50:256–261.
   PubMed Web of Science ®Google Scholar
• Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Statist Med. 2007;26:734–753.
   PubMed Web of Science ®Google Scholar
• Grohol J. Top 25 psychiatric medication prescriptions for 2013 2015 [cited 2016 Feb 10]. Available from: http://psychcentral.com/lib/top-25-psychiatric-medication-prescriptions-for-2013
   Google Scholar
• Yilmaz Z, Ceschi A, Rauber LC, et al. Escitalopram causes fewer seizures in human overdose than citalopram [comparative study]. Clin Toxicol. 2010;48:207–212.
   PubMed Web of Science ®Google Scholar
• Hayes BD, Klein-Schwartz W, Clark RF, et al. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med. 2010;39:44–48.
   PubMed Web of Science ®Google Scholar
• Corrington KA, Gatlin CC, Fields KB. A case of SSRI-induced hyponatremia. J Am Board Fam Pract/Am Board Fam Pract. 2002;15:63–65.
   PubMedGoogle Scholar
• Payandemehr B, Bahremand A, Rahimian R, et al. 5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide. Epilepsy Res. 2012;101:217–227.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K + channels by different classes of antidepressants. PLOS One. 2011;6:e28208.
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ, Thase ME, et al. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry. 2005;07:106–113.
   Google Scholar
• Tripp AC. Bupropion, a brief history of seizure risk. Gen Hosp Psychiatry. 2010;32:216–217.
   PubMed Web of Science ®Google Scholar
• Dunner DL, Zisook S, Billow AA, et al. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry. 1998;59:366–373.
   PubMed Web of Science ®Google Scholar